EUVIMEDEUVIMED entdecken
Crossref

The Dual Role of Cholesterol Metabolism in Hepatocellular Carcinoma: Mechanisms, Therapeutic Strategies and Future Perspectives

Rajabhuvaneswari Ariyamuthu, Mahalakshmi Mani, Jeevalatha Rugmangathan, Gopika U

SN Comprehensive Clinical Medicine · 17.09.2026 · 8 (1)

DOI: 10.1007/s42399-026-02685-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 17.09.2026. Verfasst von Rajabhuvaneswari Ariyamuthu und 3 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a primary cause of cancer-related mortality worldwide, with increasing incidence driven by obesity, non- alcoholic fatty liver disease (NAFLD), and chronic viral hepatitis. Emerging evidence identifies cholesterol metabolism as a critical regulator of HCC initiation, progression, and therapeutic response. Under physiological conditions, delivery maintains cholesterol homeostasis through coordinated synthesis, uptake, storage, efflux, and bile acid production. In HCC, these processes become dysregulated, resulting in improved cholesterol biosynthesis and uptake, impaired efflux, and intracellular cholesterol accumulation, which enhances membrane biogenesis, lipid raft formation, PI3K/Akt signaling, SREBP-mediated lipogenesis, fibrosis, and immune evasion. External factors such as gut microbiota dysbiosis, dietary cholesterol, NAFLD, and obesity accelerate hepatocarcinogenesis. Increased intracellular cholesterol supports tumor growth; epidemiological studies have shown an inverse association between circulating cholesterol and HCC risk that reflects the complex and context-dependent nature of cholesterol metabolism in liver cancer. This review explores cholesterol-targeting therapeutics like Statins, ezetimibe, SQLE inhibitors, SOAT1 inhibitors, and PCSK9 modulation, which demonstrate promising anti-cancer potential, yet therapeutic efficacy is limited by metabolic feedback mechanisms and tumor heterogeneity. This review also addresses developments in lipidomics, multi-omics, and precision medicine that are expected to identify cholesterol-dependent biomarkers and allow personalised therapeutic strategies to improve HCC prevention, diagnosis, and treatment. Graphical Abstract

Zitieren

APA

Ariyamuthu, R., Mani, M., Rugmangathan, J., & U, G. (2026). The Dual Role of Cholesterol Metabolism in Hepatocellular Carcinoma: Mechanisms, Therapeutic Strategies and Future Perspectives. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02685-1

Vancouver

Ariyamuthu R, Mani M, Rugmangathan J, U G. The Dual Role of Cholesterol Metabolism in Hepatocellular Carcinoma: Mechanisms, Therapeutic Strategies and Future Perspectives. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02685-1

BibTeX
@article{Ariyamuthu2026,
  author = {Ariyamuthu, Rajabhuvaneswari and Mani, Mahalakshmi and Rugmangathan, Jeevalatha and U, Gopika},
  title = {The Dual Role of Cholesterol Metabolism in Hepatocellular Carcinoma: Mechanisms, Therapeutic Strategies and Future Perspectives},
  journal = {SN Comprehensive Clinical Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1007/s42399-026-02685-1}
}
Kostenlos starten →